The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge

被引：36
作者：
Temian, Daiana Cosmina [1 ,2 ]
Pop, Laura Ancuta [1 ]
Irimie, Alexandra Iulia [3 ]
Berindan-Neagoe, Ioana [1 ,4 ,5 ]
机构：
[1] Iuliu Hatieganu Univ Med & Pharm, Res Ctr Funct Genom Biomed & Translat Med, Cluj Napoca, Romania
[2] Iuliu Hatieganu Univ Med & Pharm, Fac Med, Cluj Napoca, Romania
[3] Iuliu Hatieganu Univ Med & Pharm, Dept Prosthet Dent & Dent Mat, Div Dent Propaedeut, Aesthet, 23 Marinescu St, Cluj Napoca 40015, Romania
[4] Iuliu Hatieganu Univ Med & Pharm, MedFUTURE Res Ctr Adv Med, Cluj Napoca, Romania
[5] Oncol Inst Prof Dr I Chiricuta, Dept Funct Genom & Expt Pathol, Cluj Napoca, Romania
来源：
JOURNAL OF BREAST CANCER | 2018年 / 21卷 / 03期
关键词：
Breast neoplasms; DNA methylation; Histone code; Triple negative breast neoplasms; Untranslated RNA; LONG NONCODING RNAS; HISTONE DEACETYLASE INHIBITORS; PREDICTS SENSITIVITY; MOLECULAR PORTRAITS; DOWN-REGULATION; AXON GUIDANCE; MUTANT P53; EXPRESSION; IDENTIFICATION; BROMODOMAIN;
D O I：
10.4048/jbc.2018.21.e41
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Breast cancer has the highest incidence among all malignancies diagnosed in women. Therapies have significantly improved over the years due to extensive molecular and clinical research; in a large number of cases, targeted therapies have provided better prognosis. However, one specific subtype remains elusive to targeted therapies-the triple-negative breast cancer. This immunohistochemically defined subtype is resistant to both endocrine and targeted therapies, leading to its poor prognosis. A field that is of great promise in current cancer research is epigenetics. By studying the epigenetic mechanisms underlying tumorigenesis-DNA methylation, histone modifications, and noncoding RNAs-advances in cancer treatment, diagnosis, and prevention are possible. This review aims to synthesize the epigenetic discoveries that have been made related to the triple-negative breast cancer.
引用
收藏
页码：233 / +
页数：16
相关论文
共 50 条
  • [41] Cohort Description of Patients with Triple-Negative Basal-Like Subtype Breast Cancer Treated at the National Cancer Institute and the San Jose Hospital from 2006 to 2008
    Garcia, Oscar
    Ossa, Carlos A.
    Beltran, Maria I.
    Cano, Miguel
    Villamizar, Licet
    Arias, Ana M.
    REVISTA COLOMBIANA DE CANCEROLOGIA, 2012, 16 (02): : 91 - 99
  • [42] Triple-negative breast cancer
    Chacon, Reinaldo D.
    Costanzo, Maria V.
    BREAST CANCER RESEARCH, 2010, 12
  • [43] Triple-Negative Breast Cancer
    Foulkes, William D.
    Smith, Ian E.
    Reis-Filho, Jorge S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (20) : 1938 - 1948
  • [44] Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes
    Rakha, Emad A.
    Elsheikh, Somaia E.
    Aleskandarany, Muhammed A.
    Habashi, Hany O.
    Green, Andrew R.
    Powe, Desmond G.
    El-Sayed, Maysa E.
    Benhasouna, Ahmed
    Brunet, Jean-Sebastien
    Akslen, Lars A.
    Evans, Andy J.
    Blamey, Roger
    Reis-Filho, Jorge S.
    Foulkes, William D.
    Ellis, Ian O.
    CLINICAL CANCER RESEARCH, 2009, 15 (07) : 2302 - 2310
  • [45] What Is the Difference Between Triple-Negative and Basal Breast Cancers?
    Seal, Melanie D.
    Chia, Stephen K.
    CANCER JOURNAL, 2010, 16 (01) : 12 - 16
  • [46] Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer
    Blenman, Kim R. M.
    Marczyk, Michal
    Karn, Thomas
    Qing, Tao
    Li, Xiaotong
    Gunasekharan, Vignesh
    Yaghoobi, Vesal
    Bai, Yalai
    Ibrahim, Eiman Y.
    Park, Tristen
    Silber, Andrea
    Wolf, Denise M.
    Reisenbichler, Emily
    Denkert, Carsten
    V. Sinn, Bruno
    Rozenblit, Mariya
    Foldi, Julia
    Rimm, David L.
    Loibl, Sibylle
    Pusztai, Lajos
    CLINICAL CANCER RESEARCH, 2022, 28 (12) : 2587 - 2597
  • [47] Prognostic Significance of Combining Cytokeratin-19, E-Cadherin and Ki-67 Analysis in Triple-Negative Breast Cancer with Basal-Like and Non-Basal-Like Phenotype
    Klayech, Zahra
    Moussa, Adnene
    Souid, Moufida
    Hadhri, Rim
    Miled, Souad
    Gabbouj, Sallouha
    Remadi, Yassmine
    Faleh, Raja
    Bouaouina, Noureddine
    Zakhama, Abdelfattah
    Hassen, Elham
    CANCER INVESTIGATION, 2024, 42 (09) : 769 - 781
  • [48] Drivers and suppressors of triple-negative breast cancer
    Wu, Wanfu
    Warner, Margaret
    Wang, Li
    He, Wei-Wei
    Zhao, Ruipeng
    Guan, Xiaoxiang
    Botero, Cindy
    Huang, Bo
    Ion, Charlotte
    Coombes, Charles
    Gustafsson, Jan-Ake
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (33)
  • [49] Genomic Profiling in Triple-Negative Breast Cancer
    Liedtke, Cornelia
    Bernemann, Christof
    Kiesel, Ludwig
    Rody, Achim
    BREAST CARE, 2013, 8 (06) : 408 - 413
  • [50] An In Vitro Model of Triple-Negative Breast Cancer
    Russo, J.
    Su, Y.
    HUMAN CELL TRANSFORMATION: ADVANCES IN CELL MODELS FOR THE STUDY OF CANCER AND AGING, 2019, 1164 : 35 - 46
12345